Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile
Viruses · 2023
DOI: 10.3390/v16010046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Yan Ru Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Hepadnaviridae, Immunodeficiency Virus, Feline, Leukemia, Feline. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: City University of hong Kong, CityU, HK.
Abstract (Originalsprache)
Cat ownership is common in Chile, but data on the regional prevalence of infectious agents are limited. A sero-molecular survey of 120 client- or shelter-owned domestic cats in greater Santiago was performed. Whole blood DNA was tested for the novel hepatitis-B-like virus, domestic cat hepadnavirus (DCH) by conventional PCR (cPCR) and quantitative PCR (qPCR), and for feline leukaemia virus (FeLV) by qPCR. Point-of-care serology for FeLV p27 antigen and antibodies recognising feline immunodeficiency virus (FIV) p15 and p24 was performed. DCH DNA was detected in the serum of 2/120 cats (1.67%). Sequencing and phylogenetic analysis showed that the DCH detected in Chile occupies a position outside the main clustering of DCH in the near-complete genome tree. Progressive (antigen-positive, provirus-positive) and regressive (antigen-negative, provirus-positive) FeLV infections were identified in 6/120 (5%) and 9/120 (7.5%) of cats. A total of 2/120 (1.7%) cats had dual FeLV/FIV infection, and another 2 cats had FIV infection alone. This study shows that the global footprint of DCH includes South America with a low molecular frequency in Chile, similar to that reported in the USA. Progressive FeLV infection is relatively common in urban Chile, and male cats are at greater risk than females. Testing and control measures for pathogenic retroviruses are indicated. The potential impact of FeLV, FIV and DCH on Chile’s wildcat species is worthy of further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong.
- Centre for Animal Health and Welfare, City University of Hong Kong, Hong Kong.
- Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 7550196, Chile.
- Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life, Hong Kong.
- Storr Liver Centre, Westmead Clinical School and Westmead Institute for Medical Research, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.
- Sydney Institute for Infectious Diseases, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.
ORCID-Profile: María Paz Iturriaga, Omid Nekouei, Thomas Tu, Vanessa R Barrs, Julia A Beatty
Förderung
- City University of hong Kong
- CityU, HK
Zitieren
APA
Choi, Y. R., Iturriaga, M. P., Nekouei, O., Tu, T., Van Brussel, K., Barrs, V. R., & Beatty, J. A. (2023). Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile. Viruses. https://doi.org/10.3390/v16010046
Vancouver
Choi YR, Iturriaga MP, Nekouei O, Tu T, Van Brussel K, Barrs VR, et al. Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile. Viruses. 2023. doi:10.3390/v16010046
BibTeX
@article{Choi2023,
author = {Choi, Yan Ru and Iturriaga, María Paz and Nekouei, Omid and Tu, Thomas and Van Brussel, Kate and Barrs, Vanessa R and Beatty, Julia A},
title = {Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile},
journal = {Viruses},
year = {2023},
doi = {10.3390/v16010046}
}
EUVIMED